Based on our results, EpCAM can be used to isolate CTCs in EpCAM highly expressing tumors and in tumors with low EMT scores, such as CRC, LC, GC, BCa, EC, HNSCC, CC and PCa. The gene discussed is EPCAM; the disease is laryngotracheoesophageal cleft.